Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2008, for Wound Management Technologies, Inc. (Note: The input metadata lists "Sanara Medtech Inc.", but the filing text explicitly identifies the registrant as Wound Management Technologies, Inc.). The company operates in the advanced wound care market through its subsidiary, Wound Care Innovations, LLC, marketing the "CellerateRx" brand. The company is classified as a smaller reporting company and a shell company.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2008 | Nine Months Ended Sept 30, 2008 | Balance Sheet (Sept 30, 2008) |
|---|---|---|---|
| Total Revenue | $77,084 | $215,484 | - |
| Gross Profit (Loss) | $28,252 | $(52,873) | - |
| Net Loss | $(341,490) | $(928,228) | - |
| Cash and Equivalents | - | - | $6,387 |
| Total Current Assets | - | - | $1,092,975 |
| Total Current Liabilities | - | - | $1,622,402 |
| Stockholders' Deficiency | - | - | $(509,344) |
| Accumulated Deficit | - | - | $(13,927,610) |
Liquidity and Debt: The company has a working capital deficit of approximately $529,000. Current liabilities include $497,000 in notes payable (some in default) and $418,080 in related party line of credit payables. The company holds a related party line of credit receivable of $830,450.
Material Changes vs. Prior Period
- Revenue Decline: Revenue for the nine months ended September 30, 2008, decreased by approximately 61% to $215,484 compared to $557,365 in the same period in 2007.
- Gross Margin Reversal: The company moved from a gross profit of $349,530 in the prior year period to a gross loss of $(52,873) in the current period, driven by cost of revenue ($268,357) exceeding total revenue.
- Increased Expenses: General and Administrative expenses increased to $876,179 for the nine months ended September 30, 2008, from $556,678 in the prior year period.
- Net Loss Expansion: Net loss for the nine-month period widened significantly to $(928,228) from $(315,930) in the prior year.
- Capital Structure Changes: Significant non-cash transactions occurred, including the conversion of $1,495,664 of debt into Series A Preferred Stock and subsequent conversion of that preferred stock into 7,600,000 shares of common stock.
Outlook, Risks, and Contingencies
- Going Concern: The filing explicitly states that conditions raise substantial doubt about the company's ability to continue as a going concern. The company has continuously incurred losses and has a significant accumulated deficit. Continuation depends on obtaining additional financing or equity capital.
- Delinquent Payroll Taxes: The company is delinquent in paying federal payroll taxes. As of September 30, 2008, unpaid taxes totaled approximately $203,484, with estimated penalties and interest of $153,165 included in current liabilities.
- Debt Defaults: Certain notes payable, including a $10,000 note to an investment firm and various related party notes, are currently in default.
- Management Plans: Management plans to raise capital through private placements, issue stock for services, and obtain loans from shareholders. There are no assurances these plans will succeed.
- Risk Factors: Key risks include product liability claims, dependence on consumer perception, inability to secure financing, and exposure to litigation.
Investor Verification Checklist
- Verify the status of the $203,484 delinquent payroll tax liability and any potential IRS enforcement actions.
- Confirm the company's ability to secure the additional financing required to maintain operations for the next 12 months.
- Review the terms and default status of the $497,000 in notes payable and related party debt.
- Assess the validity of the $830,450 related party receivable and the likelihood of collection.
- Monitor the 61% revenue decline and the company's ability to reverse the negative gross margin trend.
- Check for any updates on the conversion of debt to equity and the resulting dilution to existing shareholders.